Saraceni, F., Labopin, M., Brecht, A., Kröger, N., Eder, M., Tischer, J., . . . Nagler, A. (2019). Fludarabine-treosulfan compared to thiotepa-busulfan-fludarabine or FLAMSA as conditioning regimen for patients with primary refractory or relapsed acute myeloid leukemia: A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT). J Hematol Oncol.
Παραπομπή Chicago StyleSaraceni, Francesco, et al. "Fludarabine-treosulfan Compared to Thiotepa-busulfan-fludarabine or FLAMSA As Conditioning Regimen for Patients With Primary Refractory or Relapsed Acute Myeloid Leukemia: A Study From the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)." J Hematol Oncol 2019.
Παραπομπή MLASaraceni, Francesco, et al. "Fludarabine-treosulfan Compared to Thiotepa-busulfan-fludarabine or FLAMSA As Conditioning Regimen for Patients With Primary Refractory or Relapsed Acute Myeloid Leukemia: A Study From the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)." J Hematol Oncol 2019.